Items where authors include "Ilett, E"

Article

Kottke, T, Tonne, J, Evgin, L et al. (19 more authors) (2021) Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy. Nature Communications, 12 (1). 1930. ISSN 2041-1723

Kottke, T, Evgin, L, Shim, KG et al. (12 more authors) (2017) Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence. Cancer Immunology Research, 5 (11). pp. 1029-1045. ISSN 2326-6066

Cockle, JV, Brüning-Richardson, A orcid.org/0000-0002-9862-9805, Scott, KJ orcid.org/0000-0002-5790-9579 et al. (13 more authors) (2017) Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion. Molecular Therapy - Oncolytics, 5. pp. 75-86. ISSN 2372-7705

Ilett, E, Kottke, T, Thompson, J et al. (12 more authors) (2017) Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumor therapy. Gene Therapy, 24 (1). pp. 21-30. ISSN 0969-7128

Kottke, T, Shim, KG, Alonso-Camino, V et al. (12 more authors) (2016) Immunogenicity of self tumor associated proteins is enhanced through protein truncation. Molecular Therapy - Oncolytics, 3. 16030.

Cockle, JV, Rajani, K, Zaidi, S et al. (11 more authors) (2016) Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling. Neuro-Oncology, 18 (4). pp. 518-527. ISSN 1523-5866

Rajani, K, Parrish, C, Kottke, T et al. (10 more authors) (2016) Combination therapy with reovirus and anti-PD-1 blockade controls tumor growth through innate and adaptive immune responses. Molecular Therapy, 24 (1). pp. 166-174. ISSN 1525-0016

Parrish, C, Scott, GB, Migneco, G et al. (13 more authors) (2015) Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia. Leukemia, 29 (9). 1799 - 1810. ISSN 0887-6924

Cockle, JV, Picton, S, Levesley, J et al. (7 more authors) (2015) Cell migration in paediatric glioma; characterisation and potential therapeutic targeting. British Journal of Cancer, 112 (4). pp. 693-703. ISSN 0007-0920

Zaidi, S, Blanchard, M, Shim, K et al. (13 more authors) (2015) Mutated BRAF emerges as a major effector of recurrence in a murine melanoma model after treatment with immunomodulatory agents. Molecular Therapy, 23 (5). 845 - 856. ISSN 1525-0016

Ilett, E orcid.org/0000-0002-9875-0322, Kottke, T, Donnelly, O et al. (10 more authors) (2014) Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus. Molecular Therapy, 22 (10). pp. 1851-1863. ISSN 1525-0016

Alonso-Camino, V, Rajani, K, Kottke, T et al. (12 more authors) (2014) The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site. Molecular Therapy, 22 (11). 1936 - 1948. ISSN 1525-0016

Kottke, T, Errington, F orcid.org/0000-0003-2155-534X, Pulido, J et al. (12 more authors) (2011) Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nature Medicine, 17 (7). pp. 854-859. ISSN 1078-8956

Steele, L, Errington, F orcid.org/0000-0003-2155-534X, Prestwich, R et al. (7 more authors) (2011) Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming. Molecular Cancer, 10 (1). 20. ISSN 1476-4598

Proceedings Paper

Schuelke, M, Evgin, L, Kottke, T et al. (8 more authors) (2016) Balancing Anti-Tumor Efficacy with Local Inflammatory Toxicity for the Treatment of Diffuse Intrinsic Pontine Glioma and Other Brain Tumors. In: Molecular Therapy. 19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 04-07 May 2016, Washington DC, USA. Nature Publishing Group , S77-S77.

Kottke, T, Rommelfanger, D, Shim, KG et al. (8 more authors) (2016) Escape from Tumor Dormancy Following Gene- or Viro-Therapies Is Mediated by Acquisition of a Phenotype in Which Innate Immune Surveillance Actively Drives Tumor Cell Recurrence. In: Molecular Therapy. 19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 04-07 May 2016, Washington DC, USA. Nature Publishing Group , S296-S296.

Kottke, T, Shim, KG, Evgin, L et al. (13 more authors) (2016) Immunogenicity of Self Tumor Associated Antigens Is Enhanced Through Protein Truncation. In: Molecular Therapy. 19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 04-07 May 2016, Washington DC, USA. Nature Publishing Group , S28-S28.

Alonso-Camino, V, Rajani, K, Kottke, T et al. (11 more authors) (2014) The Profile of Tumor Antigens Which Can Be Targeted By Immunotherapy Depends Upon the Tumor's Anatomical Site. In: Molecular Therapy. 7th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), 21-24 May 2014, Washington, DC, USA. Nature Publishing Group , S200-S200.

Cockle, J, Bruning-Richardson, A orcid.org/0000-0002-9862-9805, Picton, S et al. (5 more authors) (2013) PL-002. Cell Migration In Paediatric Glioma; Characterisation And Potential Therapeutic Targeting. In: NEURO-ONCOLOGY. 4th Quadrennial Meeting of the World-Federation-of-Neuro-Oncology (WFNO) held in conjunction with the 18th Annual Meeting of the Society-for-Neuro-Oncology (SNO), 21-24 Nov 2013, San Francisco, CA. , p. 173.